Pieris Pharmaceuticals Price History
PIRSDelisted Stock | USD 13.60 1.41 9.39% |
If you're considering investing in Pieris Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pieris Pharmaceuticals stands at 13.60, as last reported on the 28th of December, with the highest price reaching 15.35 and the lowest price hitting 13.26 during the day. Pieris Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11% return per unit of risk over the last 3 months. Pieris Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pieris Pharmaceuticals' Coefficient Of Variation of (911.59), risk adjusted performance of (0.08), and Variance of 7.53 to confirm the risk estimate we provide.
Pieris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Pieris |
Sharpe Ratio = -0.113
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PIRS |
Estimated Market Risk
2.82 actual daily | 25 75% of assets are more volatile |
Expected Return
-0.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pieris Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pieris Pharmaceuticals by adding Pieris Pharmaceuticals to a well-diversified portfolio.
Pieris Pharmaceuticals Stock Price History Chart
There are several ways to analyze Pieris Stock price data. The simplest method is using a basic Pieris candlestick price chart, which shows Pieris Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Pieris Stock Price History Data
The price series of Pieris Pharmaceuticals for the period between Sun, Sep 29, 2024 and Sat, Dec 28, 2024 has a statistical range of 3.7 with a coefficient of variation of 3.37. The price distribution for the period has arithmetic mean of 16.5. The median price for the last 90 days is 16.56. The company completed stock split (1:80) on 23rd of April 2024.Open | High | Low | Close | Volume | ||
12/28/2024 | 15.01 | 15.35 | 13.26 | 13.60 | ||
12/13/2024 | 15.01 | 15.35 | 13.26 | 13.60 | 51,728 | |
12/12/2024 | 16.34 | 16.58 | 16.11 | 16.13 | 7,539 | |
12/11/2024 | 16.85 | 16.93 | 16.24 | 16.60 | 11,535 | |
12/10/2024 | 16.41 | 17.36 | 16.30 | 17.00 | 110,783 | |
12/09/2024 | 16.24 | 16.60 | 16.24 | 16.57 | 6,638 | |
12/06/2024 | 16.61 | 16.61 | 16.31 | 16.33 | 2,014 | |
12/05/2024 | 16.58 | 16.58 | 16.25 | 16.36 | 4,662 | |
12/04/2024 | 16.23 | 16.86 | 16.20 | 16.70 | 27,311 | |
12/03/2024 | 16.73 | 16.76 | 16.10 | 16.10 | 4,802 | |
12/02/2024 | 16.40 | 17.00 | 16.31 | 16.43 | 34,503 | |
11/29/2024 | 16.25 | 16.25 | 16.25 | 16.25 | 2,367 | |
11/27/2024 | 17.09 | 17.09 | 16.52 | 16.83 | 3,431 | |
11/26/2024 | 16.99 | 17.07 | 16.84 | 17.07 | 6,186 | |
11/25/2024 | 15.85 | 17.00 | 15.85 | 16.84 | 29,727 | |
11/22/2024 | 15.89 | 16.97 | 15.89 | 16.77 | 16,045 | |
11/21/2024 | 15.39 | 16.01 | 15.39 | 15.93 | 11,220 | |
11/20/2024 | 15.59 | 16.25 | 15.59 | 16.01 | 8,047 | |
11/19/2024 | 15.18 | 16.25 | 15.15 | 15.59 | 46,462 | |
11/18/2024 | 15.53 | 16.09 | 15.37 | 15.44 | 31,742 | |
11/15/2024 | 15.85 | 16.14 | 15.79 | 15.87 | 6,405 | |
11/14/2024 | 16.25 | 16.97 | 15.85 | 15.95 | 96,583 | |
11/13/2024 | 16.47 | 16.85 | 16.01 | 16.10 | 97,178 | |
11/12/2024 | 15.84 | 16.54 | 15.72 | 16.12 | 60,217 | |
11/11/2024 | 16.84 | 16.88 | 15.69 | 15.97 | 40,814 | |
11/08/2024 | 16.48 | 16.83 | 16.10 | 16.83 | 6,141 | |
11/07/2024 | 16.55 | 16.69 | 16.36 | 16.48 | 6,544 | |
11/06/2024 | 17.06 | 17.70 | 16.55 | 16.70 | 273,309 | |
11/05/2024 | 16.95 | 17.26 | 16.88 | 17.00 | 14,248 | |
11/04/2024 | 17.21 | 17.35 | 16.97 | 16.98 | 18,582 | |
11/01/2024 | 17.25 | 17.47 | 17.10 | 17.30 | 4,608 | |
10/31/2024 | 17.00 | 17.33 | 16.72 | 17.25 | 6,691 | |
10/30/2024 | 16.90 | 16.90 | 16.51 | 16.87 | 5,884 | |
10/29/2024 | 17.00 | 17.20 | 17.00 | 17.00 | 5,538 | |
10/28/2024 | 16.75 | 17.00 | 16.70 | 17.00 | 12,326 | |
10/25/2024 | 16.51 | 16.99 | 16.51 | 16.94 | 1,157 | |
10/24/2024 | 16.55 | 17.00 | 16.55 | 17.00 | 10,162 | |
10/23/2024 | 16.50 | 16.95 | 16.38 | 16.95 | 12,254 | |
10/22/2024 | 16.63 | 16.83 | 16.35 | 16.42 | 23,533 | |
10/21/2024 | 16.91 | 16.91 | 16.66 | 16.80 | 2,314 | |
10/18/2024 | 16.85 | 16.92 | 16.85 | 16.92 | 2,842 | |
10/17/2024 | 16.71 | 16.96 | 16.52 | 16.93 | 3,046 | |
10/16/2024 | 16.36 | 16.50 | 16.23 | 16.49 | 3,443 | |
10/15/2024 | 16.11 | 16.40 | 16.09 | 16.25 | 9,248 | |
10/14/2024 | 16.25 | 16.30 | 16.25 | 16.27 | 1,500 | |
10/11/2024 | 16.12 | 16.55 | 16.12 | 16.55 | 3,617 | |
10/10/2024 | 16.43 | 16.50 | 16.28 | 16.35 | 3,519 | |
10/09/2024 | 16.07 | 16.17 | 16.07 | 16.17 | 4,190 | |
10/08/2024 | 16.18 | 16.18 | 16.03 | 16.04 | 1,861 | |
10/07/2024 | 16.18 | 16.20 | 16.17 | 16.18 | 1,471 | |
10/04/2024 | 16.30 | 16.30 | 16.25 | 16.26 | 2,102 | |
10/03/2024 | 16.55 | 16.55 | 16.29 | 16.29 | 8,491 | |
10/02/2024 | 16.89 | 16.89 | 16.23 | 16.55 | 2,781 | |
10/01/2024 | 16.50 | 16.83 | 16.17 | 16.61 | 21,128 | |
09/30/2024 | 16.45 | 16.69 | 16.25 | 16.58 | 4,251 | |
09/27/2024 | 16.59 | 16.59 | 16.16 | 16.16 | 26,486 | |
09/26/2024 | 16.60 | 17.00 | 16.16 | 16.16 | 8,323 | |
09/25/2024 | 17.06 | 17.20 | 16.46 | 16.49 | 6,801 | |
09/24/2024 | 16.83 | 17.23 | 16.83 | 17.07 | 1,572 | |
09/23/2024 | 17.00 | 17.20 | 16.58 | 17.20 | 2,220 | |
09/20/2024 | 17.35 | 17.50 | 16.51 | 17.24 | 9,523 |
About Pieris Pharmaceuticals Stock history
Pieris Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pieris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pieris Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pieris Pharmaceuticals stock prices may prove useful in developing a viable investing in Pieris Pharmaceuticals
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts. Pieris Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 124 people.
Pieris Pharmaceuticals Stock Technical Analysis
Pieris Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
All Next | Launch Module |
Pieris Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pieris Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Pieris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pieris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.08) | |||
Jensen Alpha | (0.31) | |||
Total Risk Alpha | (0.39) | |||
Treynor Ratio | 5.04 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Pieris Stock
If you are still planning to invest in Pieris Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pieris Pharmaceuticals' history and understand the potential risks before investing.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |